Marek K.
- Country
- Poland
- Department
- N/A
Research Overview
- Efficacy and Safety Assessment of Budesonide, Glycopyrronium, and Formoterol Fumarate MDI in Adults and Adolescents with Severe Asthma
- A Phase 2b, Multicenter, Randomized, Double-blind, Parallel group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis
- Efficacy and Safety Evaluation of Verekitug (UPB-101) in Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 51 of 293 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular emphasis on severe asthma and chronic obstructive pulmonary disease (COPD).
- Severe and inadequately controlled asthma
- Moderate to very severe COPD
- Exacerbation management
The investigator's focus includes patients with frequent exacerbations and specific biomarker profiles, such as elevated peripheral blood eosinophils.
Innovative Therapeutics
The investigator explores advanced therapeutic approaches using combination inhalation therapies and targeted biological treatments.
- Multiple-component inhaler therapies
- Biological treatments
- Personalized medicine approaches
Their work involves evaluating novel therapeutic combinations for optimal patient outcomes in respiratory care.
Clinical Outcomes
The investigator focuses on key clinical endpoints in respiratory medicine, particularly lung function improvement and exacerbation reduction.
- Pulmonary function assessment
- Exacerbation frequency
- Treatment efficacy evaluation
Their research emphasizes measuring therapeutic impacts on respiratory disease control and patient well-being.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.